Homologous recombination mediates stable Fah gene integration and phenotypic correction in tyrosinaemia mouse-model.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Junge, NormanYuan, Qinggong
Vu, Thu Huong
Krooss, Simon
Bednarski, Christien
Balakrishnan, Asha
Cathomen, Toni
Manns, Michael P
Baumann, Ulrich
Sharma, Amar Deep
Ott, Michael
Issue Date
2018-02-27
Metadata
Show full item recordAbstract
To stably correct tyrosinaemia in proliferating livers of fumarylacetoacetate-hydrolase knockout (Fah-/-)mice by homologous-recombination-mediated targeted addition of theFahgene.Citation
Homologous recombination mediates stable Fah gene integration and phenotypic correction in tyrosinaemia mouse-model. 2018, 10 (2):277-286 World J HepatolAffiliation
TWINCORE, Zentrum für experimentelle und klinischeInfektionsforschung GmbH, Feodor-Lynen-Str. 7, 30625 Hannover, Germany.Journal
World journal of hepatologyPubMed ID
29527263Type
ArticleLanguage
enISSN
1948-5182ae974a485f413a2113503eed53cd6c53
10.4254/wjh.v10.i2.277
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
Related articles
- Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
- Authors: VanLith C, Guthman R, Nicolas CT, Allen K, Du Z, Joo DJ, Nyberg SL, Lillegard JB, Hickey RD
- Issue date: 2018 Nov
- Sleeping Beauty transposon system is a reliable gene delivery tool for hereditary tyrosinaemia type 1 disease gene therapy: size of the foreign gene decides the timing of stable integration into the host chromosomes.
- Authors: Pan XJ, Ma ZZ, Zhang QJ, Fan L, Li QH
- Issue date: 2012
- Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells.
- Authors: Wu G, Liu N, Rittelmeyer I, Sharma AD, Sgodda M, Zaehres H, Bleidissel M, Greber B, Gentile L, Han DW, Rudolph C, Steinemann D, Schambach A, Ott M, Schöler HR, Cantz T
- Issue date: 2011 Jul
- Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
- Authors: Hickey RD, Mao SA, Glorioso J, Elgilani F, Amiot B, Chen H, Rinaldo P, Marler R, Jiang H, DeGrado TR, Suksanpaisan L, O'Connor MK, Freeman BL, Ibrahim SH, Peng KW, Harding CO, Ho CS, Grompe M, Ikeda Y, Lillegard JB, Russell SJ, Nyberg SL
- Issue date: 2016 Jul 27
- High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
- Authors: Eggenhofer E, Doenecke A, Renner P, Slowik P, Piso P, Geissler EK, Schlitt HJ, Dahlke MH, Popp FC
- Issue date: 2010 May